30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

SPIEGELMAN DANIEL K

Track

Insider profile

SPIEGELMAN DANIEL K's trades of Kyverna Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-07 2026-04-07
PrS Proposed sale
11,303
491.50
US$35,606 		11,303 491.50 US$35,606
2026-03-31 2026-03-31
PrS Proposed sale
88,079
100.23
US$361,879 		88,079 100.23 US$361,879
2024-06-04 2024-06-04
PrS Proposed sale
84,214
299.18
US$100,679 		84,214 299.18 US$100,679
2024-06-04 2024-06-04
PlS Planned sale
3,788 -10.3%
22.05
US$83,525 		3,788 -10.3% 22.05 US$83,525
2024-06-04 2024-06-03
PlS Planned sale
3,788 -9.4%
22.04
US$83,488 		3,788 -9.4% 22.04 US$83,488
2024-06-03 2024-06-03
PrS Proposed sale
3,788
22.04
US$83,488 		3,788 22.04 US$83,488
2023-06-02 2023-06-02
PrS Proposed sale
8,638
23.01
US$198,760 		8,638 23.01 US$198,760
2023-06-02 2023-06-02
PlS Planned sale
8,638 -17.6%
23.01
US$198,760 		8,638 -17.6% 23.01 US$198,760
2022-06-06 2022-06-06
PlS Planned sale
6,424 -15.9%
19.25
US$123,673 		6,424 -15.9% 19.25 US$123,673
2021-06-17 2021-06-17
PlS Planned sale
3,139 -11.9%
30.52
US$95,795 		3,139 -11.9% 30.52 US$95,795
2021-06-01 2021-05-28
PlS Planned sale
7,142 -34.7%
28.99
US$207,023 		7,142 -34.7% 28.99 US$207,023
2019-04-03 2019-04-01
PlS Planned sale
13,473 -22.1%
89.00
US$1,199,097 		13,473 -22.1% 89.00 US$1,199,097
2019-03-29 2019-03-27
PlS Planned sale
100 -0.2%
90.00
US$9,000 		100 -0.2% 90.00 US$9,000